In section Releases

Phreesia Investors Face July 13 Deadline in Securities Fraud Suit

Investors who purchased Phreesia, Inc. common stock between May 8, 2025, and March 30, 2026, face a July 13, 2026, deadline to apply as lead plaintiff in a pending securities class action. The lawsuit alleges the company concealed slowing demand and weakened pharmaceutical marketing commitments within its Network Solutions segment.

Phreesia Investors Face July 13 Deadline in Securities Fraud Suit

The litigation, spearheaded by the Rosen Law Firm, claims that Phreesia executives issued misleading statements regarding the firm's financial health, specifically concerning reduced visibility in key revenue streams. Shareholders who suffered losses due to these allegedly concealed facts are eligible to participate in the class action, which seeks to recover damages through a contingency fee arrangement that requires no out-of-pocket costs from investors.

Those interested in serving as a representative party must file a motion with the court by the mid-July cutoff. While a class has not yet been certified, investors retain the right to select their own counsel or remain absent class members without forfeiting their ability to share in a potential future recovery. Interested parties can contact Phillip Kim at the Rosen Law Firm to discuss the case or register their participation through the firm's online portal.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!